Improvement of Outcomes in High-risk Myeloma (Optimum/Muknine Trial) | Martin Kaiser | #ASH24
HealthTree Foundation
1,275 views
Dr. Martin Kaiser discusses his research on high-risk myeloma, focusing on personalized treatments and genetic risk markers. He emphasizes the importance of genetic testing, such as FISH and gene expression, to improve diagnosis and treatment, and highlights the success of his clinical trial in improving survival rates for high-risk patients.
Link to ASH playlist: https://healthtree.org/blood-cancer/u...
ASH Abstract: Extended Intensified Consolidation and Maintenance Improve Ultra High-Risk Multiple Myeloma Patient Outcome – Long-Term Follow-up of the Ukmra Optimum/Muknine Trial
#ASH24 #Myeloma #mmsm
Follow HealthTree: https://linktr.ee/HealthTreeUniversity
1 Comments
Improvement of Outcomes in High-risk Myeloma (Optimum/Muknine Trial) | Martin Kaiser | #ASH24
HealthTree Foundation
1,275 views
Dr. Martin Kaiser discusses his research on high-risk myeloma, focusing on personalized treatments and genetic risk markers. He emphasizes the importance of genetic testing, such as FISH and gene expression, to improve diagnosis and treatment, and highlights the success of his clinical trial in improving survival rates for high-risk patients.
Link to ASH playlist: https://healthtree.org/blood-cancer/u...
ASH Abstract: Extended Intensified Consolidation and Maintenance Improve Ultra High-Risk Multiple Myeloma Patient Outcome – Long-Term Follow-up of the Ukmra Optimum/Muknine Trial
#ASH24 #Myeloma #mmsm
Follow HealthTree: https://linktr.ee/HealthTreeUniversity